-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $12

Benzinga·09/30/2026 10:24:01
Citigroup analyst Geoff Meacham initiates coverage on Nuvation Bio (NYSE:NUVB) with a Buy rating and announces Price Target of $12.